CARLYLE SECURED LENDING INC (CGBD)

US8722801029 - Common Stock

17.18  +0.09 (+0.53%)

After market: 17.18 0 (0%)

Fundamental Rating

5

Overall CGBD gets a fundamental rating of 5 out of 10. We evaluated CGBD against 212 industry peers in the Capital Markets industry. CGBD has an average financial health and profitability rating. CGBD is valued correctly, but it does not seem to be growing.



5

1. Profitability

1.1 Basic Checks

In the past year CGBD was profitable.
CGBD had a positive operating cash flow in the past year.
In the past 5 years CGBD has always been profitable.
CGBD had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 4.57%, CGBD is in line with its industry, outperforming 58.85% of the companies in the same industry.
CGBD has a Return On Equity (9.73%) which is in line with its industry peers.
The Return On Invested Capital of CGBD (4.59%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGBD is significantly below the industry average of 10.67%.
The 3 year average ROIC (4.05%) for CGBD is below the current ROIC(4.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.57%
ROE 9.73%
ROIC 4.59%
ROA(3y)5.44%
ROA(5y)3.87%
ROE(3y)11.74%
ROE(5y)8.43%
ROIC(3y)4.05%
ROIC(5y)3.97%

1.3 Margins

CGBD has a better Profit Margin (36.74%) than 76.08% of its industry peers.
CGBD's Profit Margin has improved in the last couple of years.
CGBD's Operating Margin of 45.51% is fine compared to the rest of the industry. CGBD outperforms 76.08% of its industry peers.
In the last couple of years the Operating Margin of CGBD has declined.
CGBD has a Gross Margin of 48.05%. This is comparable to the rest of the industry: CGBD outperforms 44.02% of its industry peers.
In the last couple of years the Gross Margin of CGBD has declined.
Industry RankSector Rank
OM 45.51%
PM (TTM) 36.74%
GM 48.05%
OM growth 3Y-2.27%
OM growth 5Y-2.72%
PM growth 3Y144.1%
PM growth 5Y14.29%
GM growth 3Y-1.77%
GM growth 5Y-2.2%

6

2. Health

2.1 Basic Checks

CGBD has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CGBD has less shares outstanding
The debt/assets ratio for CGBD has been reduced compared to a year ago.

2.2 Solvency

CGBD has an Altman-Z score of 0.74. This is a bad value and indicates that CGBD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CGBD (0.74) is comparable to the rest of the industry.
The Debt to FCF ratio of CGBD is 4.25, which is a neutral value as it means it would take CGBD, 4.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.25, CGBD is in the better half of the industry, outperforming 68.90% of the companies in the same industry.
A Debt/Equity ratio of 1.07 is on the high side and indicates that CGBD has dependencies on debt financing.
CGBD's Debt to Equity ratio of 1.07 is in line compared to the rest of the industry. CGBD outperforms 44.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 4.25
Altman-Z 0.74
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.03 indicates that CGBD has no problem at all paying its short term obligations.
CGBD's Current ratio of 2.03 is fine compared to the rest of the industry. CGBD outperforms 69.86% of its industry peers.
A Quick Ratio of 2.03 indicates that CGBD has no problem at all paying its short term obligations.
CGBD has a better Quick ratio (2.03) than 69.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 2.03

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.81% over the past year.
The Earnings Per Share has been growing slightly by 3.95% on average over the past years.
CGBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.59%.
Measured over the past years, CGBD shows a small growth in Revenue. The Revenue has been growing by 3.09% on average per year.
EPS 1Y (TTM)8.81%
EPS 3Y11.87%
EPS 5Y3.95%
EPS growth Q2Q16.67%
Revenue 1Y (TTM)16.59%
Revenue growth 3Y9.89%
Revenue growth 5Y3.09%
Revenue growth Q2Q11.86%

3.2 Future

The Earnings Per Share is expected to decrease by -36.79% on average over the next years. This is quite bad
The Revenue is expected to decrease by -4.63% on average over the next years.
EPS Next Y-2.2%
EPS Next 2Y-5.41%
EPS Next 3Y-36.79%
EPS Next 5YN/A
Revenue Next Year-2.1%
Revenue Next 2Y-4.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.18, the valuation of CGBD can be described as very reasonable.
CGBD's Price/Earnings ratio is a bit cheaper when compared to the industry. CGBD is cheaper than 79.43% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.28, CGBD is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.36, the valuation of CGBD can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CGBD is valued a bit cheaper than the industry average as 77.03% of the companies are valued more expensively.
CGBD is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.18
Fwd PE 8.36

4.2 Price Multiples

CGBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CGBD is cheaper than 92.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.78
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as CGBD's earnings are expected to decrease with -36.79% in the coming years.
PEG (NY)N/A
PEG (5Y)2.07
EPS Next 2Y-5.41%
EPS Next 3Y-36.79%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.36%, CGBD is a good candidate for dividend investing.
CGBD's Dividend Yield is a higher than the industry average which is at 7.27.
CGBD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 9.36%

5.2 History

The dividend of CGBD has a limited annual growth rate of 4.01%.
CGBD has been paying a dividend for over 5 years, so it has already some track record.
CGBD has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.01%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

CGBD pays out 104.78% of its income as dividend. This is not a sustainable payout ratio.
CGBD's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP104.78%
EPS Next 2Y-5.41%
EPS Next 3Y-36.79%

CARLYLE SECURED LENDING INC

NASDAQ:CGBD (5/3/2024, 7:00:00 PM)

After market: 17.18 0 (0%)

17.18

+0.09 (+0.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap872.57M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 9.36%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.18
Fwd PE 8.36
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)2.07
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 9.73%
ROCE
ROIC
ROICexc
ROICexgc
OM 45.51%
PM (TTM) 36.74%
GM 48.05%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.03
Quick Ratio 2.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)8.81%
EPS 3Y11.87%
EPS 5Y
EPS growth Q2Q
EPS Next Y-2.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.59%
Revenue growth 3Y9.89%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y